Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The hypothesis underlying this study is that failure to recognise the role of lactose intolerance among patients with ulcerative colitis has led to inappropriate dietary advice and treatment with drugs that contain lactose as a filler. These failures exacerbate symptoms and lead to the unnecessary use of immune suppressant drugs.
There is disagreement amongst researchers regarding the amount of lactose needed to cause symptoms in those who are lactose intolerance. The general consensus is that the amount of lactose in a glass of milk (12 grams) is enough to cause mild symptoms in most patients who are lactose intolerant (1). However, there have been a number of studies and case studies that argue that much lower amounts can cause symptoms (2, 3, 4, 5). This could be as little as 0.02 grams (6).
Ulcerative colitis is a chronic relapsing inflammatory disease of the colon and rectum, characterised by recurrent episodes of abdominal pain and profuse diarrhoea. The prevalence of lactose intolerance in patients with ulcerative colitis is not greater than in the general population, but there is no evidence as to whether these patients are more sensitive to lactose.
This study will identify the threshold at which symptoms of lactose intolerance develop in those who have both lactose intolerance and ulcerative colitis, to provide appropriate advice and treatment in the management of patients with these conditions.
| Condition | Intervention | Phase |
|---|---|---|
|
Lactose Intolerance Ulcerative Colitis |
Dietary Supplement: Lactose in water |
Phase 0 |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Crossover Time Perspective: Prospective |
| Official Title: | A Study to Determine the Threshold of Lactose Ingestion That Provokes Symptoms in Lactose Intolerant People Who Also Have Ulcerative Colitis |
- Symptoms of pain and diarrhoea [ Time Frame: Over 48 hours ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 48 |
| Study Start Date: | April 2007 |
| Study Completion Date: | June 2007 |
| Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Patients with known lactose intolerance | Dietary Supplement: Lactose in water |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with lactose intolerance
Inclusion Criteria:
- Confirmed lactose intolerance demonstrated with a lactose intolerance test.
- Confirmed ulcerative colitis demonstrated with histological and radiological tests.
- Adherence to a lactose free diet for at least four days before the start of the study.
Exclusion Criteria:
- Failure to adhere to a lactose free diet.
- Pregnancy.
- Unwillingness to comply with study outline.
Contacts and Locations| United Kingdom | |
| Leicester General Hospital | |
| Leicester, Leicestershire, United Kingdom, LE5 4PW | |
| Principal Investigator: | John F Mayberry, DSc MD | University Hospitals, Leicester |
More Information
No publications provided
| Responsible Party: | Carolyn Burden, University Hospitals of Leicester |
| ClinicalTrials.gov Identifier: | NCT00403923 History of Changes |
| Other Study ID Numbers: | UHL 10253 |
| Study First Received: | November 24, 2006 |
| Last Updated: | February 13, 2009 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by University Hospitals, Leicester:
|
Lactose intolerance Ulcerative colitis Lactose Threshold |
Additional relevant MeSH terms:
|
Colitis Colitis, Ulcerative Lactose Intolerance Ulcer Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Colonic Diseases |
Intestinal Diseases Inflammatory Bowel Diseases Malabsorption Syndromes Carbohydrate Metabolism, Inborn Errors Metabolism, Inborn Errors Genetic Diseases, Inborn Metabolic Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013